[Pfizer Inc.](https://www.pfizer.com)

April 21, 2026

$10,000–$250,000 per project; total budget up to $500,000; preferred project length 18 months

Funds independent education projects to improve knowledge and best practices for maintenance therapy in first-line HER2+ metastatic breast cancer.

--- ## Description This opportunity supports independent medical education projects aimed at enhancing the knowledge and competence of healthcare professionals regarding maintenance therapy in first-line HER2+ metastatic breast cancer (MBC). The grant seeks to address knowledge gaps in therapy combinations, evolving treatment paradigms, safety profiles, adverse event management, and sequencing strategies. Eligible educational formats include live and virtual sessions, peer-to-peer education, articles, webinars, and multimedia resources, all designed to empower healthcare professionals with the latest clinical insights and best practices in HER2+ MBC care. --- ## Due Dates - April 21, 2026: Submission Deadline — full application due by 23:59 Eastern Standard Time --- ## Funding Amount - Individual project requests: $10,000–$250,000 - Estimated total available budget: $500,000 - Preferred project duration: 18 months (projects may be shorter or longer) - Overhead capped at 28% of total budget per Pfizer policy --- ## Eligibility - **Geographic Scope:** United States - **Eligible Applicants:** - Medical, dental, nursing, allied health, and pharmacy professional schools - Healthcare institutions (large and small) - Professional organizations/medical societies - Medical education companies - Other entities with a mission related to healthcare professional education and/or healthcare improvement - **Ineligible:** Individuals and unaffiliated medical practice groups - **Additional Criteria:** - Only organizations may apply; must be able to receive funds directly from Pfizer Inc. - For continuing education credit, the applicant organization must be accredited. - The project/program lead must be an employee or contractor of the applying organization. --- ## Application Process - Applications must be submitted via the [Pfizer CyberGrants portal](http://www.cybergrants.com/pfizer/knowledge). - First-time users should create a password prior to the submission deadline. - Complete all required sections and upload a project proposal (max 15 pages, exclusive of references). - For the application, select: - “Competitive Grant?”: Yes - Primary Area of Interest: Oncology – Breast – KG - Competitive Grant Program Name: 2026 ONC US Maintenance MBC IME - Ensure all organization information is current in the portal. - Review the full RFP for detailed proposal requirements (goals, needs assessment, audience, design, evaluation, dissemination, timeline, budget). --- ## Additional Information - Only independent education projects are supported; clinical research or efficacy studies are not eligible. - All applicants will be notified of decisions via email by May 8, 2026. - Projects are expected to start June/July 2026 and end by December 2027. - Grant agreements are required; modifications are limited except for legal conflicts. --- ## External Links - [Full RFP (PDF)](https://cdn.pfizer.com/pfizercom/2026-03/2026-ONC-US-MaintenanceMBCIME.pdf?VersionId=Uwkqbm_oFb11zdM4pDS4aQ0Rpi3gmHBD) - [Pfizer CyberGrants Portal](http://www.cybergrants.com/pfizer/knowledge) - [Pfizer Inc. Homepage](https://www.pfizer.com) --- ## Contact Information | Contact | Email | Phone | |------------------------|------------------------------------|-----------------| | Grant Officer: Lori Carpenter | lori.carpenter@pfizer.com | 1-800-879-3477 | For technical portal issues, use the “Technical Questions” link at the bottom of the CyberGrants portal. ---

Pfizer Independent Medical Education Grant Request for Proposals: Maintenance Therapy in HER2+ Metastatic Breast Cancer (MBC)

Sign in to see full grant listing